# 2025年11月15日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 欧洲危重病医学会 (ESICM) 2025年循环性休克与血流动力学监测指南

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41236566](https://pubmed.ncbi.nlm.nih.gov/41236566)
**期刊：** Intensive care medicine
**PMID：** 41236566
**DOI：** 10.1007/s00134-025-08137-z

### 第一部分 原文与翻译

**英文原标题：** ESICM guidelines on circulatory shock and hemodynamic monitoring 2025.

**英文摘要原文：**
OBJECTIVE: These European Society of Intensive Care Medicine (ESICM) guidelines provide recommendations for the diagnosis of shock and hemodynamic monitoring for adult critically ill patients.

METHODS: An international panel of experts formulated PICO-formatted questions, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was applied to assess evidence and formulate recommendations. In the absence of strong evidence, panelists issued ungraded good practice statements (UGPS).

RESULTS: Panelists issued 50 statements. Among others, skin perfusion should be monitored using the assessment of capillary refill time, and this may be complemented by the assessment of skin temperature and mottling (UGPS). In patients with a central venous catheter, serial measurements of (central) venous oxygen saturation and of the veno-arterial difference in carbon dioxide partial pressure should be performed (UGPS). In patients with persistent shock after initial fluid resuscitation, fluid responsiveness should be assessed before continuing fluid resuscitation (UGPS). It is recommended to use dynamic variables over static markers of preload for predicting fluid responsiveness, when applicable (graded statement). Cardiac output (CO) and/or stroke volume should be monitored in patients who do not respond to initial therapy (UGPS). Arterial pressure should be monitored with an arterial catheter in shock that is not responsive to initial therapy and/or requiring vasopressor infusion (UGPS), and central venous pressure should be measured in patients who have a central venous catheter (UGPS). Panelists suggest using echocardiography as the first-line imaging modality to assess the type of shock (graded statement). Echocardiographically defined phenotypes of left and right ventricular dysfunction may be of prognostic significance (UGPS).

CONCLUSIONS: The panel made 50 recommendations on shock diagnosis and hemodynamic monitoring.

**中文摘要译文：**
目的: 本欧洲危重病医学会 (ESICM) 指南旨在为成年危重症患者的休克诊断和血流动力学监测提供推荐意见。

方法: 一个国际专家小组构建了PICO格式的问题，并采用推荐分级、评估、制定与评价 (GRADE) 方法来评估证据并形成推荐意见。在缺乏强有力证据的情况下，专家组发布了未分级的良好实践声明 (UGPS)。

结果: 专家组共发布了50条声明。其中包括：应通过评估毛细血管再充盈时间来监测皮肤灌注，并可辅以皮肤温度和花斑的评估 (UGPS)。对于留置中心静脉导管的患者，应连续测量（中心）静脉血氧饱和度以及动静脉二氧化碳分压差 (UGPS)。对于初始液体复苏后持续休克的患者，在继续液体复苏前应评估其液体反应性 (UGPS)。在适用情况下，推荐使用动态变量而非静态前负荷指标来预测液体反应性 (分级推荐)。对于初始治疗无反应的患者，应监测其心输出量 (CO) 和/或每搏输出量 (UGPS)。对于初始治疗无反应和/或需要输注血管加压药的休克患者，应使用动脉导管监测动脉压 (UGPS)；对于留置中心静脉导管的患者，应测量中心静脉压 (UGPS)。专家组建议将超声心动图作为评估休克类型的一线影像学方法 (分级推荐)。通过超声心动图定义的左右心室功能障碍表型可能具有预后意义 (UGPS)。

结论: 专家组就休克诊断和血流动力学监测提出了50条推荐意见。

### 第二部分 AI 大师评价

该指南由欧洲危重病医学会 (ESICM) 权威发布，旨在为成人循环性休克与血流动力学监测提供最新的循证指导。通过系统性地采用GRADE方法，国际专家组针对临床关键问题，制定了50条具体的推荐意见与良好实践声明。其核心价值在于强调了从宏观循环到微循环的综合评估，推荐使用毛细血管再充盈时间、动静脉二氧化碳分压差等指标，并提倡以超声心动图作为休克分型的一线工具。这份指南为全球危重症医师提供了标准化的决策框架，对规范休克患者的管理、提升治疗同质化具有重要的临床指导意义。

---

## 2. ICU中护士主导的家庭沟通干预的特点与效果：一项系统综述和Meta分析

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41236180](https://pubmed.ncbi.nlm.nih.gov/41236180)
**期刊：** Critical care medicine
**PMID：** 41236180
**DOI：** 10.1097/CCM.0000000000006952

### 第一部分 原文与翻译

**英文原标题：** Characteristics and Effectiveness of Nurse-Led Family Communication Interventions in the ICU: A Systematic Review and Meta-Analysis.

**英文摘要原文：**
OBJECTIVE: To determine the characteristics and effectiveness of nurse-led family communication interventions in the ICU.

DATA SOURCES: PubMed, Web of Science, PsychInfo, CINAHL, Embase, Cochrane Library, and relevant article citations from January 1995 to July 2025.

STUDY SELECTION: We included randomized controlled trials (RCTs) and quasi-experimental studies evaluating nurse-led family communication interventions in adult ICUs.

DATA EXTRACTION: Two independent reviewers assessed evidence levels and risk of bias using the Cochrane tool and the Joanna Briggs Institute's Critical Appraisal Tools. Data were synthesized according to the Preferred Reporting Items for Systematic Reviews guidelines, and interventions were summarized with the Template for Intervention Description and Replication Checklist.

DATA SYNTHESIS: Seven RCTs and seven quasi-experimental studies were included. The most common nurse-family communication model was an in-person, structured, and dynamically tailored intervention during the patient's ICU stay. Nurses played five core roles: information delivery and clarification, emotional support, family assessment, family meeting facilitation, and transitional support. Bedside ICU nurses led information delivery and multidimensional family assessments. Internal research nurses handled information clarification, structured needs assessment, and family meeting coordination. External research nurses focused on family meeting support, structured emotional support, and transitional care. Although the interventions may improve communication quality (standardized mean differences [SMD] = 0.26) and reduce hospital length of stay (LOS) (mean differences [MD] = -3.87 d), they appear to have limited effects on psychologic distress, satisfaction, ICU LOS, or mortality; they may also increase family meeting frequency/duration and lower overall costs.

CONCLUSIONS: The conclusions of our systematic review are limited by considerable heterogeneity in intervention intensity, implementer profiles, and adaptation descriptions. Future interventions should define optimal dosage and outline best practices for evidence-based intervention tailoring and implementation. Healthcare institutions should integrate specialized nursing roles, such as training bedside nurses or establishing dedicated communication facilitators. This approach may leverage nurses' expertise to enhance communication quality and improve outcomes.

**中文摘要译文：**
目的: 旨在明确ICU中护士主导的家庭沟通干预的特点及其有效性。

数据来源: PubMed、Web of Science、PsychInfo、CINAHL、Embase、Cochrane Library，以及1995年1月至2025年7月间的相关文章引文。

研究筛选: 我们纳入了评估成人ICU中护士主导的家庭沟通干预的随机对照试验（RCTs）和准实验研究。

数据提取: 两名独立的评审员使用Cochrane工具和乔安娜·布里格斯研究所的批判性评估工具评估了证据级别和偏倚风险。数据根据系统综述首选报告项目（PRISMA）指南进行合成，并使用干预措施描述与复制模板清单（TIDieR）对干预措施进行了总结。

数据合成: 共纳入七项RCTs和七项准实验研究。最常见的护士-家庭沟通模式是在患者ICU住院期间进行的、面对面的、结构化的、并根据情况动态调整的干预。护士扮演了五个核心角色：信息传递与澄清、情感支持、家庭评估、家庭会议协调以及过渡期支持。床旁ICU护士主导信息传递和多维度家庭评估。内部研究护士负责信息澄清、结构化需求评估和家庭会议协调。外部研究护士则专注于家庭会议支持、结构化情感支持和过渡期照护。尽管这些干预措施可能提高沟通质量（标准化均数差 [SMD] = 0.26）并缩短住院时间（均数差 [MD] = -3.87天），但它们对心理困扰、满意度、ICU住院时间或死亡率的影响似乎有限；同时，它们也可能增加家庭会议的频率/时长并降低总体成本。

结论: 由于干预强度、实施者背景和适应性调整描述方面存在显著的异质性，本系统综述的结论受到限制。未来的干预研究应界定最佳的干预剂量，并为循证干预的个性化调整与实施勾画最佳实践。医疗机构应整合专门的护理角色，例如培训床旁护士或设立专职沟通协调员。这种方法可以利用护士的专业知识来提升沟通质量并改善结局。

### 第二部分 AI 大师评价

该研究通过系统综述与Meta分析，全面评估了ICU中由护士主导的家庭沟通干预的特征与效果。其核心发现揭示了这类干预在提升沟通质量和缩短总住院天数方面的潜力，但对患者心理及死亡率等硬终点影响有限，这为临床实践提供了重要参考。该文的价值在于系统性地梳理了护士在医患沟通中的多重关键角色，并指出了当前研究存在较大异质性的局限性。研究结论强调了未来需要标准化干预方案并设立专职沟通护理岗位，这对于优化ICU人文关怀和资源配置具有重要的指导意义。

---

## 3. 结节病：最新进展综述。

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41232941](https://pubmed.ncbi.nlm.nih.gov/41232941)
**期刊：** The European respiratory journal
**PMID：** 41232941
**DOI：** 10.1183/13993003.01324-2025

### 第一部分 原文与翻译

**英文原标题：** Sarcoidosis: A State-Of-The-Art Review.

**英文摘要原文：**
.

**中文摘要译文：**
摘要不可用。

### 第二部分 AI 大师评价

该文献是一篇关于结节病的最新进展综述，发表于权威的《欧洲呼吸杂志》。文章旨在系统性地总结当前关于结节病在病理生理、诊断标准、治疗策略及未来研究方向的最新知识和共识。作为一篇“State-Of-The-Art”综述，其核心价值在于为临床医生和研究人员提供了该领域最前沿、最全面的参考信息，对指导临床实践和启发未来研究具有重要意义。由于原文未提供摘要，无法深入了解其具体论点，但其标题和发表期刊预示了其高质量和权威性。

---

## 4. 欧洲呼吸学会与欧洲胸外科医师学会关于肺癌根治性治疗适应性评估的临床实践指南

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41232938](https://pubmed.ncbi.nlm.nih.gov/41232938)
**期刊：** The European respiratory journal
**PMID：** 41232938
**DOI：** 10.1183/13993003.00156-2025

### 第一部分 原文与翻译

**英文原标题：** European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.

**英文摘要原文：**
A multidisciplinary panel of lung cancer experts with a special interest in functional evaluation of lung cancer patients, and lung cancer patient representatives, has been facilitated by the European Society of Thoracic Surgeons and the European Respiratory Society to provide healthcare professionals with practical and up-to-date recommendations for the assessment of patients' fitness for curative intent treatments for lung cancer. The panel formulated four PICO (population, intervention, comparison and outcomes) questions and seven complementary narrative questions. Both types of questions were assigned to groups of at least two experts. A medical librarian conducted the literature searches, and the authors selected relevant studies based on predefined inclusion criteria. Risk of bias was assessed using the QUIPS (Quality in Prognosis Studies) tool. Data were summarised and the certainty of evidence was assessed with GRADE (Grading of Recommendations, Assessment, Development and Evaluations) and the Evidence to Decisions framework was used to formulate recommendations. A series of multidisciplinary recommendations was formulated about the utilisation of pulmonary function tests, split lung function values, exercise tests, cardiologic testing, and the role of prehabilitation, sublobar resections, risk scores and comorbidities in selecting patients for curative intent treatment.

**中文摘要译文：**
在欧洲胸外科医师学会和欧洲呼吸学会的推动下，一个由对肺癌患者功能评估有特别专长的多学科专家组及患者代表组成的小组，旨在为医疗专业人员提供评估患者肺癌根治性治疗适应性的实用、前沿建议。该小组制定了四个PICO（人群、干预、比较和结局）问题和七个补充性叙述问题。这两类问题均被分配给至少由两名专家组成的小组进行研究。一名医学图书管理员进行了文献检索，作者们根据预定的纳入标准筛选了相关研究。研究的偏倚风险采用QUIPS（预后研究质量）工具进行评估。研究数据经过汇总，证据的确定性通过GRADE（推荐、评估、制定与评价的分级）系统进行评估，并使用“证据到决策”框架来制定推荐意见。最终，该指南就肺功能测试、分侧肺功能值、运动试验、心脏功能测试的应用，以及康复预处理、亚肺叶切除、风险评分和合并症在筛选适合根治性治疗患者中的作用，制定了一系列多学科推荐意见。

### 第二部分 AI 大师评价

该指南由欧洲两大权威学会（ERS与ESTS）联合发布，旨在为肺癌根治性治疗的术前适应性评估提供一套系统、权威的临床指导。其通过严谨的PICO问题构建、系统性文献回顾，并采用GRADE和证据到决策框架，确保了推荐意见的科学性和可靠性。指南的核心价值在于，它明确了肺功能、运动心肺功能、心脏评估及康复预处理等关键环节的标准化流程，为临床医生优化患者选择、降低手术风险、改善预后提供了清晰的循证依据。作为该领域的最新纲领性文件，它对规范全球范围内的肺癌诊疗实践具有重要的指导意义。

---

## 5. 抑制炎性体可改善直向同源模型的多囊肾病

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41231953](https://pubmed.ncbi.nlm.nih.gov/41231953)
**期刊：** Proceedings of the National Academy of Sciences of the United States of America
**PMID：** 41231953
**DOI：** 10.1073/pnas.2511204122

### 第一部分 原文与翻译

**英文原标题：** Inhibition of the inflammasome ameliorates orthologous polycystic kidney disease.

**英文摘要原文：**
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disease. Limited treatment options lead to renal failure in the vast majority of affected individuals. Novel therapeutic approaches are needed. Recent evidence has identified inflammation as an important driver of ADPKD. We analyzed transcriptional profiles in an orthologous Pkd1 mouse model and found a strong upregulation of the inflammasome pathway. To investigate the role of inflammasomes on cyst formation and kidney function, we modulated inflammasome activity through genetic targeting of the essential inflammasome component or treatment with the inflammasome inhibitor MCC950. Genetic deletion of Pycard/Asc in mutant mice significantly reduced cyst formation, and kidney function was improved. Reductions were seen in inflammation, fibrosis, and urinary excretion of IL-18. Analogous results were obtained through tubule-specific inactivation of or treatment of mutant mice with the inflammasome inhibitor MCC950. These findings demonstrate that inflammasomes act as drivers of disease severity in an orthologous mouse model of ADPKD. We pinpoint a separate, epithelial pool of inflammasomes in the diseased kidney and identify inflammasome inhibition as a promising strategy for the treatment of ADPKD.

**中文摘要译文：**
常染色体显性多囊肾病（ADPKD）是最常见的遗传性肾脏疾病。有限的治疗选择导致绝大多数患者出现肾功能衰竭。亟需新的治疗方法。近期证据已表明，炎症是ADPKD的重要驱动因素。我们分析了一个直向同源Pkd1小鼠模型的转录谱，发现炎性体通路显著上调。为探究炎性体在囊肿形成和肾功能中的作用，我们通过基因靶向关键炎性体组分或使用炎性体抑制剂MCC950来调节其活性。在突变小鼠中基因敲除Pycard/Asc可显著减少囊肿形成，并改善肾功能。观察到炎症、纤维化以及尿液中IL-18的排泄均有所减少。通过肾小管特异性失活或使用炎性体抑制剂MCC950治疗突变小鼠也获得了类似结果。这些发现表明，在ADPKD的直向同源小鼠模型中，炎性体是疾病严重程度的驱动因素。我们准确定位了病变肾脏中一个独立的上皮细胞炎性体库，并确定抑制炎性体是治疗ADPKD的一种有前景的策略。

### 第二部分 AI 大师评价

本研究旨在阐明炎性体在常染色体显性多囊肾病（ADPKD）发病机制中的作用。研究团队运用直向同源小鼠模型，通过基因敲除与药物抑制相结合的方法，证实了抑制炎性体活性能够显著减轻囊肿生长、改善肾功能。此项发现不仅揭示了炎症作为ADPKD疾病进展驱动因素的关键通路，更重要的是，它将炎性体抑制确定为一种极具潜力的ADPKD新疗法，为临床治疗策略的开发提供了坚实的实验依据和明确的靶点。

---

## 6. 一种二元分布的效应因子通过靶向谱系特异性免疫因子来调节真菌对果蝇的宿主偏好性

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41231943](https://pubmed.ncbi.nlm.nih.gov/41231943)
**期刊：** Proceedings of the National Academy of Sciences of the United States of America
**PMID：** 41231943
**DOI：** 10.1073/pnas.2518127122

### 第一部分 原文与翻译

**英文原标题：** A binary-distributed effector modulates fungal host preference for drosophilids by targeting a lineage-specific immune factor.

**英文摘要原文：**
Unlike host-specific parasites, broad-spectrum pathogens often exhibit an enigmatic strain/race-level preference for infecting particular host species over others. Here, we identify a polymorphic effector (termed Bhe1) that exhibits a binary presence-absence distribution pattern among strains of the entomopathogenic fungus . Gene deletion and overexpression in present strains revealed that this gene functions as a virulence factor against  species but dispensable for infection of mosquitoes, beetles, and locusts. Through targeted protein screening, we verified that Bhe1 targets a drosophilid-specific factor with an unknown function (termed Dsff1). The expression of  is induced in  upon fungal infection and is controlled by the Toll pathway. Survival of  RNA interference (RNAi) flies was impaired after infection with the wild-type but not Δ strain of . Overexpression of  and  in  respectively, suppresses and promotes fly antifungal immunity. Further investigations reveal that Dsff1 binds Bombardier (Bbd), and Bhe1 blocks their interaction. Consistent with Bbd's role as a Toll-mediated immune factor, both  and  RNAi flies exhibit similar defects in the secretion of immune factors, including antifungal peptides. While revealing the mechanistic control of parasite host preference, our identification of a novel immune factor in  underscores a compelling instance of host-parasite evolutionary arms race.

**中文摘要译文：**
与宿主特异性寄生虫不同，广谱病原体通常表现出一种令人费解的菌株/种族水平上的偏好，即更倾向于感染特定的宿主物种。本研究中，我们鉴定出一种多态性效应因子（命名为Bhe1），该因子在昆虫病原真菌的菌株中呈现出有-无二元分布模式。在含有该基因的菌株中进行基因敲除和过表达实验表明，该基因作为一种毒力因子，对果蝇物种具有致病性，但对于感染蚊子、甲虫和蝗虫则非必需。通过靶向蛋白质筛选，我们证实Bhe1靶向一个功能未知的果蝇特异性因子（命名为Dsff1）。在真菌感染后，Dsff1在果蝇体内的表达被诱导上调，并受Toll信号通路的调控。使用野生型而非ΔBhe1菌株感染后，经过Dsff1 RNA干扰（RNAi）处理的果蝇存活率受损。在果蝇中分别过表达Dsff1和Bhe1，会相应地抑制和促进果蝇的抗真菌免疫。进一步的研究揭示，Dsff1与Bombardier（Bbd）蛋白结合，而Bhe1则阻断了它们的相互作用。与Bbd作为Toll通路介导的免疫因子的作用相一致，Dsff1和Bhe1 RNAi果蝇均在免疫因子（包括抗真菌肽）的分泌方面表现出相似的缺陷。我们的研究在揭示寄生生物宿主偏好性的机理控制的同时，通过鉴定出果蝇体内一个新的免疫因子，也凸显了宿主-寄生生物之间进化军备竞赛的一个引人注目的实例。

### 第二部分 AI 大师评价

本研究旨在揭示广谱病原真菌在菌株水平上表现出宿主偏好性的分子机制。研究者通过基因编辑和蛋白质筛选等方法，发现了一种名为Bhe1的真菌效应因子，其存在与否决定了对果蝇的致病力。核心发现是，Bhe1通过靶向果蝇中一个前所未知的谱系特异性免疫因子Dsff1，阻断其与免疫蛋白Bbd的相互作用，从而抑制宿主的Toll通路介导的抗真菌免疫。该研究不仅为理解病原体的宿主选择性提供了精细的分子证据，还鉴定出一个新的宿主免疫因子，是阐明宿主-病原体协同进化“军备竞赛”的一个经典范例，具有重要的科研价值。

---

## 7. 用于感染性疾病诊断的宿主免疫应答分析

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40796180](https://pubmed.ncbi.nlm.nih.gov/40796180)
**期刊：** The Journal of infectious diseases
**PMID：** 40796180
**DOI：** 10.1093/infdis/jiaf428

### 第一部分 原文与翻译

**英文原标题：** Host Immune Response Profiling for the Diagnosis of Infectious Diseases.

**英文摘要原文：**
Recent advances in infectious disease diagnostics include the development, validation, and commercialization of new tests that measure host gene expression profiles or inflammatory protein concentrations. Interrogating host immune responses may help separate infectious from non-infectious inflammation, differentiate infection types, and/or predict sepsis severity/subtype. This review summarizes the current state-of-the-art in host response (HR) diagnostics for infectious diseases with a focus on test accuracy. Few studies have assessed the potential impact of HR testing on patient outcomes. We summarize current clinical evidence gaps and describe the types of studies needed to inform optimal integration in clinical practice.

**中文摘要译文：**
近年来，感染性疾病诊断领域的最新进展包括开发、验证和商业化了测量宿主基因表达谱或炎症蛋白浓度的新型检测方法。探究宿主免疫应答可能有助于区分感染性与非感染性炎症，鉴别感染类型，和/或预测脓毒症的严重程度/亚型。本篇综述聚焦于检测准确性，总结了用于感染性疾病的宿主应答（HR）诊断技术的最新前沿进展。很少有研究评估过宿主应答检测对患者结局的潜在影响。我们总结了当前临床证据的空白，并描述了为实现其在临床实践中的最佳整合所需的研究类型。

### 第二部分 AI 大师评价

该综述聚焦于通过分析宿主免疫应答来诊断感染性疾病的前沿领域。文章系统总结了基于宿主基因表达谱或炎症蛋白浓度的新型诊断方法的最新进展与检测精度，并敏锐地指出了当前研究的空白——即缺乏这些技术对患者最终结局影响的临床证据。此项工作不仅为研究人员梳理了该领域的现状，更重要的是，它明确了未来所需的研究方向，对推动这些创新诊断技术从实验室走向临床、实现其最大价值具有重要的指导意义。

---

## 8. 在可检测到HIV-1病毒血症反弹之前，抗病毒单核细胞数量增加

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40628395](https://pubmed.ncbi.nlm.nih.gov/40628395)
**期刊：** The Journal of infectious diseases
**PMID：** 40628395
**DOI：** 10.1093/infdis/jiaf367

### 第一部分 原文与翻译

**英文原标题：** Antiviral Monocytes Increase Prior to Detectable HIV-1 Rebound Viremia.

**英文摘要原文：**
The persistence of human immunodeficiency virus 1 (HIV-1) proviruses in latently infected cells allows viremia to resume upon treatment cessation. To characterize the resulting immune response, we compared plasma proteomics and single-cell transcriptomics of peripheral blood mononuclear cells before, during, and after detectable plasma viremia. We observed unique transcriptional signatures prior to viral rebound, including a significant increase in CD16++ monocytes with increased antiviral gene expression. Inflammatory proteins were identified in plasma after detectable rebound. Identifying early signals of imminent viral rebound after treatment cessation will aid in the development of strategies to prolong time to viral rebound and cure HIV-1.

**中文摘要译文：**
人类免疫缺陷病毒1型（HIV-1）前病毒在潜伏感染细胞中的持续存在，使得病毒血症在治疗中断后得以恢复。为明确由此产生的免疫应答特征，我们比较了在可检测到血浆病毒血症之前、期间和之后的血浆蛋白质组学以及外周血单个核细胞的单细胞转录组学数据。我们在病毒反弹前观察到了独特的转录特征，包括CD16++单核细胞的显著增多，且其抗病毒基因表达上调。在检测到病毒反弹后，血浆中鉴定出多种炎性蛋白。识别治疗中断后病毒即将反弹的早期信号，将有助于制定延长病毒反弹时间及治愈HIV-1的策略。

### 第二部分 AI 大师评价

本研究旨在揭示HIV-1治疗中断后病毒反弹前的早期免疫信号。研究团队创新性地结合了血浆蛋白质组学与单细胞转录组学技术，发现了一个关键现象：在病毒血症可被检测到之前，具有抗病毒基因表达特征的CD16++单核细胞已显著增多。这一发现将病毒反弹的监测窗口前移，从关注反弹后的炎症反应转向识别反弹前的细胞免疫变化，为开发预测病毒反弹的生物标志物、延长治疗中断后的缓解期乃至探索HIV-1治愈策略提供了重要的科学依据和新思路。

---

## 9. 两项国际临床试验中非洲与非非洲国家中性粒细胞计数的差异

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40447276](https://pubmed.ncbi.nlm.nih.gov/40447276)
**期刊：** The Journal of infectious diseases
**PMID：** 40447276
**DOI：** 10.1093/infdis/jiaf291

### 第一部分 原文与翻译

**英文原标题：** Differences in Neutrophil Counts Between African and Non-African Countries in 2 International Clinical Trials.

**英文摘要原文：**
BACKGROUND: Differences in absolute neutrophil count (ANC) between African and non-African populations have been reported. Neutropenia has also been reported during rifamycin use. ANC values in current tables that assign severity grades to clinical or laboratory events (National Cancer Institute Common Terminology Criteria for Adverse Events [CTCAE] and the National Institute of Allergy and Infectious Diseases Division of AIDS [DAIDS]) might not consistently be applicable among different populations.

METHODS: During 2 international tuberculosis treatment trials, 337 participants received 10 mg/kg of rifampin, and 3 groups of 361, 81, and 81 participants received 10, 15, and 20 mg/kg of rifapentine, respectively, for 2 months of daily treatment. ANC was measured at baseline and after 2, 4, 6, 8, and 12 weeks of treatment. CTCAE versions 2.0-4.0 and DAIDS version 2.0 define neutropenia grade 3 as ANC 500-999 cells/μL and ANC 400-599 cells/μL, respectively. We analyzed factors associated with neutropenia.

RESULTS: Baseline median ANC was lower in Black African participants than in Black non-African participants (P = .004). CTCAE-defined grade 3 or higher neutropenia occurred in 32 (28 in Africa) participants. Proportions did not differ between rifapentine doses. Only 4 events would have been reported by DAIDS criteria. All neutropenia events resolved spontaneously without interrupting treatment. Enrollment in an African country was an independent factor associated with the development of neutropenia.

CONCLUSIONS: Differences in baseline median ANC can result in misclassification of adverse events or inappropriate clinical management. Development and use of population-specific normal values of ANC could improve guidance for research and clinical management.

**中文摘要译文：**
背景：已有报道指出非洲与非非洲人群的绝对中性粒细胞计数（ANC）存在差异。在使用利福霉素类药物期间也曾报道出现中性粒细胞减少症。现行用于为临床或实验室事件划分严重性等级的表格（美国国家癌症研究所不良事件通用术语标准 [CTCAE] 及美国国家过敏和传染病研究所艾滋病分部 [DAIDS] 标准）中的ANC值可能不一致地适用于不同人群。

方法：在两项国际结核病治疗试验中，337名参与者接受了10 mg/kg的利福平治疗，另有三组分别为361、81和81名的参与者分别接受了10、15和20 mg/kg的利福喷汀治疗，均为每日给药，持续两个月。在基线以及治疗后第2、4、6、8和12周测量了ANC。CTCAE 2.0-4.0版和DAIDS 2.0版分别将3级中性粒细胞减少症定义为ANC 500-999 cells/μL和ANC 400-599 cells/μL。我们分析了与中性粒细胞减少症相关的因素。

结果：非洲黑人参与者的基线ANC中位数低于非非洲黑人参与者（P = .004）。根据CTCAE定义，32名参与者（其中28名在非洲）发生了3级或更高级别的中性粒细胞减少症。不同利福喷汀剂量组间的发生比例无差异。若按DAIDS标准，则仅会上报4例事件。所有中性粒细胞减少症事件均在未中断治疗的情况下自发缓解。在非洲国家入组是发生中性粒细胞减少症的一个独立相关因素。

结论：基线ANC中位数的差异可能导致不良事件的错误分类或不恰当的临床管理。开发并使用针对特定人群的ANC正常值范围，可以为研究和临床管理提供更好的指导。

### 第二部分 AI 大师评价

本研究通过对两项国际结核病治疗试验数据的二次分析，旨在探究非洲与非非洲人群在中性粒细胞计数（ANC）上的差异及其对不良事件评估的影响。研究关键发现，非洲黑人参与者的基线ANC显著更低，且在非洲国家入组是发生中性粒细胞减少症的独立风险因素，这凸显了现有不良事件分级标准（如CTCAE）在不同种族人群中可能存在适用性问题。该研究的价值在于，它有力地指出了建立并应用基于特定人群的ANC正常值范围的必要性，以避免不良事件的错误分类，从而优化临床试验监测和患者管理。

---

## 10. 大肠杆菌III型分泌系统2与血流感染患者死亡率相关

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40404560](https://pubmed.ncbi.nlm.nih.gov/40404560)
**期刊：** The Journal of infectious diseases
**PMID：** 40404560
**DOI：** 10.1093/infdis/jiaf265

### 第一部分 原文与翻译

**英文原标题：** Escherichia coli Type III Secretion System 2 Is Associated With Patient Mortality in Bloodstream Infections.

**英文摘要原文：**
BACKGROUND: Escherichia coli has an extensive accessory genome, though its role in affecting patient mortality is unknown.

METHODS: We performed whole genome sequencing with E. coli bacteremia isolates. Pan-genome analysis was used to identify flexible genomic islands associated with in-hospital attributable mortality. Genomic islands of interest were investigated experimentally.

RESULTS: We included 193 E. coli genomes. Two genomic islands were co-present within 41 (21%) genomes and associated with increased attributable mortality in an adjusted analysis (Odds ratio 3.0; 95% confidence interval 1.1-7.9; p=0.03). The two genomic islands together contain genes homologous to a type III secretion system (T3SS): 1) E. coli type III secretion system 2 (ETT2), encoding genes homologous to a T3SS basal body and needle complex, and 2) an ETT2 accessory region (ETT2-AR) encoding genes homologous to a T3SS needle tip, translocases, and adhesin. ETT2/ETT2-AR increased resistance to complement-mediated growth restriction by inhibiting classical complement pathway activation and impacted E. coli-host cell interactions by increasing adhesion to and death of mammalian cells.

CONCLUSIONS: Genomic islands ETT2 and ETT2-AR are homologous to a T3SS, co-localize within specific E. coli lineages, associate with increased mortality, and increase bacterial virulence through resistance to complement and enhanced host cell adhesion and death.

**中文摘要译文：**
背景: 大肠杆菌拥有广泛的附件基因组，但其在影响患者死亡率中的作用尚不明确。

方法: 我们对大肠杆菌菌血症分离株进行了全基因组测序。通过泛基因组分析，我们识别了与院内归因死亡率相关的柔性基因岛。并对感兴趣的基因岛进行了实验研究。

结果: 本研究共纳入193个大肠杆菌基因组。在41个（21%）基因组中共同存在两个基因岛，并且在校正分析中与归因死亡率增加相关（比值比3.0；95%置信区间1.1-7.9；p=0.03）。这两个基因岛共同包含与III型分泌系统（T3SS）同源的基因：1）大肠杆菌III型分泌系统2（ETT2），其编码与T3SS基体和针状复合体同源的基因；2）一个ETT2辅助区（ETT2-AR），其编码与T3SS针尖、易位蛋白和黏附素同源的基因。ETT2/ETT2-AR通过抑制经典补体途径的激活，增强了对补体介导的生长抑制的抵抗力，并通过增加对哺乳动物细胞的黏附和导致其死亡，影响了大肠杆菌与宿主细胞的相互作用。

结论: 基因岛ETT2和ETT2-AR与T3SS同源，在特定的大肠杆菌谱系中共存，与死亡率增加相关，并通过抵抗补体以及增强宿主细胞黏附和死亡来增加细菌的毒力。

### 第二部分 AI 大师评价

本研究旨在探究大肠杆菌附件基因组与其导致的菌血症患者死亡率之间的关系。研究团队创新性地结合了全基因组测序、泛基因组分析与实验验证，成功识别出两个与患者死亡率显著相关的基因岛（ETT2和ETT2-AR），它们共同构成一个功能性的III型分泌系统。该研究不仅揭示了ETT2/ETT2-AR通过抵抗补体和增强宿主细胞毒性来提升细菌毒力的关键机制，也为临床上识别高风险感染患者和开发新的干预策略提供了重要的分子靶点和理论依据。

---

## 11. 近平滑念珠菌的氟康唑耐药性上升：一项对美国参考实验室十年间（2015-2024）血培养分离株的分析

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40360931](https://pubmed.ncbi.nlm.nih.gov/40360931)
**期刊：** The Journal of infectious diseases
**PMID：** 40360931
**DOI：** 10.1093/infdis/jiaf249

### 第一部分 原文与翻译

**英文原标题：** Increasing Fluconazole Resistance in Candida parapsilosis: A 10-Year Analysis of Blood Culture Isolates at a US Reference Laboratory (2015-2024).

**英文摘要原文：**
Antifungal susceptibility testing among 1740 Candida parapsilosis blood isolates submitted to a United States reference laboratory (2015-2024) revealed a significant increase in fluconazole resistance from 8.2% to 20.3% (odds ratio [OR] per year, 1.13 [95% confidence interval {CI}, 1.06-1.20]; P < .001), with notable acceleration since 2021. Voriconazole resistance remained stable over this period. Micafungin resistance was rare, but intermediate susceptibility significantly increased, especially after 2021 (OR per year, 1.42 [95% CI, 1.25-1.63]; P < .001). These findings highlight important recent shifts in antifungal susceptibility among C parapsilosis isolates, emphasizing the need for ongoing surveillance and stewardship.

**中文摘要译文：**
对2015年至2024年间送至美国一家参考实验室的1740株近平滑念珠菌血源分离株进行的抗真菌药物敏感性测试显示，氟康唑的耐药率从8.2%显著增加至20.3%（年比值比[OR]为1.13，95%置信区间{CI}为1.06-1.20；P < .001），且自2021年以来加速增长尤为明显。在此期间，伏立康唑的耐药性保持稳定。米卡芬净的耐药性罕见，但中介敏感度显著上升，尤其是在2021年之后（年比值比[OR]为1.42，95%置信区间{CI}为1.25-1.63；P < .001）。这些发现揭示了近平滑念珠菌分离株抗真菌药物敏感性的近期重要变化，强调了持续监测和合理用药的必要性。

### 第二部分 AI 大师评价

本研究通过对美国一家参考实验室十年间（2015-2024）的大样本血培养分离株进行回顾性分析，旨在揭示近平滑念珠菌的抗真菌药物敏感性变化趋势。其核心发现是氟康唑耐药率显著且加速上升，以及米卡芬净中介敏感度的增加，这一发现具有重要的临床预警价值。该研究以其时间跨度长、样本量大的特点，为临床选择经验性抗真菌药物提供了关键的最新循证依据，并凸显了加强抗真菌药物管理和耐药性监测的紧迫性。

---

速递结束，祝您工作愉快！